SG Americas Securities LLC cut its stake in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 97.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,519 shares of the semiconductor company's stock after selling 71,587 shares during the period. SG Americas Securities LLC's holdings in Synopsys were worth $737,000 as of its most recent SEC filing.
A number of other institutional investors and hedge funds have also made changes to their positions in SNPS. Paradiem LLC increased its stake in shares of Synopsys by 4.8% in the fourth quarter. Paradiem LLC now owns 11,270 shares of the semiconductor company's stock worth $5,470,000 after buying an additional 519 shares during the last quarter. Park Place Capital Corp grew its stake in Synopsys by 142.4% in the fourth quarter. Park Place Capital Corp now owns 383 shares of the semiconductor company's stock worth $186,000 after purchasing an additional 225 shares in the last quarter. Janney Capital Management LLC acquired a new stake in Synopsys during the fourth quarter valued at approximately $6,082,000. Advisory Alpha LLC grew its position in shares of Synopsys by 3.8% in the 4th quarter. Advisory Alpha LLC now owns 691 shares of the semiconductor company's stock worth $335,000 after acquiring an additional 25 shares in the last quarter. Finally, Nisa Investment Advisors LLC increased its holdings in shares of Synopsys by 6.4% in the 4th quarter. Nisa Investment Advisors LLC now owns 46,293 shares of the semiconductor company's stock valued at $22,469,000 after acquiring an additional 2,778 shares during the last quarter. 85.47% of the stock is currently owned by institutional investors and hedge funds.
Synopsys Stock Performance
Shares of NASDAQ:SNPS traded up $13.65 during midday trading on Thursday, reaching $526.36. The company had a trading volume of 740,891 shares, compared to its average volume of 1,119,082. Synopsys, Inc. has a 1-year low of $457.52 and a 1-year high of $629.38. The firm has a market cap of $81.36 billion, a price-to-earnings ratio of 36.25, a price-to-earnings-growth ratio of 3.57 and a beta of 1.12. The company has a fifty day simple moving average of $517.68 and a two-hundred day simple moving average of $521.54.
Insider Activity
In related news, CRO Richard S. Mahoney sold 20,838 shares of Synopsys stock in a transaction on Wednesday, January 15th. The shares were sold at an average price of $506.01, for a total value of $10,544,236.38. Following the completion of the sale, the executive now owns 1,460 shares of the company's stock, valued at approximately $738,774.60. The trade was a 93.45 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.66% of the stock is currently owned by corporate insiders.
Wall Street Analysts Forecast Growth
A number of analysts have weighed in on the stock. Redburn Atlantic assumed coverage on shares of Synopsys in a report on Monday, January 13th. They set a "buy" rating and a $600.00 target price on the stock. Rosenblatt Securities reiterated a "buy" rating and set a $635.00 price target on shares of Synopsys in a research report on Wednesday, December 4th. Wells Fargo & Company dropped their price objective on shares of Synopsys from $570.00 to $540.00 and set an "equal weight" rating on the stock in a report on Monday, January 13th. Robert W. Baird decreased their target price on shares of Synopsys from $644.00 to $630.00 and set an "outperform" rating for the company in a research report on Thursday, December 5th. Finally, Berenberg Bank started coverage on Synopsys in a report on Tuesday, October 15th. They set a "buy" rating and a $660.00 price target on the stock. One analyst has rated the stock with a hold rating and eleven have given a buy rating to the company's stock. According to MarketBeat.com, the company currently has an average rating of "Moderate Buy" and a consensus price target of $641.82.
Check Out Our Latest Research Report on SNPS
About Synopsys
(
Free Report)
Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.
Featured Articles
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.